AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Fallopian Tube Neoplasms

7
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05116189
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)
Active_Not_Recruiting · Phase 3
NCT00063401
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Completed · Phase 2
NCT00191646
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Completed · Phase 3
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Fallopian Tube Neoplasms
🏥 Names
Disease Name
Fallopian Tube Neoplasms
Alias Names
Fallopian Tube Cancer; Fallopian Tube Neoplasms; Fallopian Tube Carcinoma
Topic Type
group
🧬 Ontology Classifications
DisGeNET Type
group
UMLS Type
Neoplastic Process
MeSH Class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
Disease Ontology
1963; 1964
DisGeNET
C0015558
🔍 Raw view — every non-empty column on this row (26 fields)
name
Fallopian Tube Neoplasms
alias name
Fallopian Tube Cancer; Fallopian Tube Neoplasms; Fallopian Tube Carcinoma
topic type
group
disgenet disease type
group
umls disease type
Neoplastic Process
mesh disease class
Female Urogenital Diseases and Pregnancy Complications; Neoplasms
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C13
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS001036
disgenet id
C0015558
mesh id
D005185
do id
1963; 1964

⚗️ Related Ingredients

1 · shared evidence

📋 Clinical Trials

7 · subject of clinical study
NCT05116189 Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-r
→ Ovarian Cancer|Carcinoma, Ovarian Epithelial|Fallo
NCT00063401 Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanc
→ Ovarian Cancer|Peritoneal Neoplasms|Fallopian Tube
NCT00191646 An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That
→ Genital Neoplasms, Female|Fallopian Tube Neoplasms
NCT00391118 Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastau
→ Ovarian Cancer|Fallopian Tube Neoplasms|Peritoneal
NCT01462890 Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standar
→ Genital Diseases, Female|Ovarian Diseases|Ovarian
NCT03648489 Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube o
→ Ovarian Cancer|Ovarian Neoplasms|Ovarian Carcinosa
NCT04498117 Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovari
→ Carcinoma, Ovarian Epithelial|Ovarian Neoplasms|Ov
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables